Keisuke Kosumi

Kumamoto University

Papers

1

Total Citations

2

H-Index

1

About

Keisuke Kosumi is a surgical oncologist whose research focuses on the aggressive management of advanced gastric cancer, particularly through the emerging paradigm of conversion surgery. His most cited work, a 2024 case report, documents a remarkable complete pathological response in a patient with stage IV gastric cancer and multiple liver metastases following treatment with S-1 plus oxaliplatin (SOX) therapy. This contribution highlights the potential of modern perioperative chemotherapy to render initially unresectable disease amenable to curative-intent resection, offering new hope for patients with traditionally poor prognoses. While his citation count is still growing, this study underscores his commitment to pushing the boundaries of multimodal treatment strategies. Kosumi’s work is significant for demonstrating that even extensive metastatic disease can be reversed, challenging conventional surgical limits and emphasizing the importance of individualized, response-driven care. His research aligns with broader efforts to integrate systemic therapy and surgery in gastrointestinal oncology, making him a notable voice in the evolving landscape of gastric cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Conversion surgery for stage IV gastric cancer with multiple liver metastases with a complete pathological response to S-1 plus oxaliplatin therapy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Kumamoto University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago